Co-Inhibition of MYC and BCL2 Signaling Is a Potentially Effective Strategy for Treatment of Double Hit and Triple Hit B-Cell Lymphomas

被引：0
|
作者：
Cinar, Munevver [1 ]
Rosenfelt, Fred [1 ]
Rokshar, Sepehr [1 ]
Pillai, Rajzt [1 ]
Lopategui, Jean [1 ]
Cervania, Melissa [1 ]
Cinar, Bekir [1 ]
Alkan, Serhan [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
LABORATORY INVESTIGATION | 2015年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1825
引用
收藏
页码：456A / 456A
页数：1
相关论文
共 50 条
  • [1] Co-Inhibition of MYC and BCL2 Signaling Is a Potentially Effective Strategy for Treatment of Double Hit and Triple Hit B-Cell Lymphomas
    Cinar, Munevver
    Rosenfelt, Fred
    Rokshar, Sepehr
    Pillai, Raja
    Lopategul, Jean
    Cervania, Melissa
    Cinar, Bekir
    Alkan, Serhan
    MODERN PATHOLOGY, 2015, 28 : 456A - 456A
  • [2] Concurrent inhibition of MYC and BCL2 is a potentially effective treatment strategy for double hit and triple hit B-cell lymphomas
    Cinar, Munevver
    Rosenfelt, Fred
    Rokhsar, Sepehr
    Lopategui, Jean
    Pillai, Raju
    Cervania, Melissa
    Pao, Andy
    Cinar, Bekir
    Alkan, Serhan
    LEUKEMIA RESEARCH, 2015, 39 (07) : 730 - 738
  • [3] Co-targeting of MYC and BCL2 signaling is a promising treatment strategy for double hit and triple hit B-cell lymphomas
    Cinar, Munevver
    Rosenfelt, Fred
    Rokshar, Sepehr
    Pillai, Raju
    Lopategui, Jean
    Cervania, Melissa
    Cinar, Bekir
    Alkan, Serhan
    MOLECULAR CANCER RESEARCH, 2015, 13
  • [4] Treatment and Clinical Outcomes of High Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements (Double Hit/Triple Hit Lymphomas)
    Habermann, Thomas M.
    Macon, William R.
    Maurer, Matthew J.
    Ketterling, Rhett P.
    Kurtin, Paul J.
    Feldman, Andrew L.
    Vaidya, Rakhee
    Cerhan, James R.
    Ansell, Stephen
    Porrata, Luis
    Nowakowski, Grzegorz S.
    Witzig, Thomas E.
    McPhail, Ellen D.
    BLOOD, 2016, 128 (22)
  • [5] High grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6: Double hit and triple hit lymphomas and double expressing lymphoma
    Rosenthal, Allison
    Younes, Anas
    BLOOD REVIEWS, 2017, 31 (02) : 37 - 42
  • [6] Double-hit B-cell Lymphomas With BCL6 and MYC Translocations Are Aggressive, Frequently Extranodal Lymphomas Distinct From BCL2 Double-hit B-cell Lymphomas
    Pillai, Raju K.
    Sathanoori, Malini
    Van Oss, Stephen Branden
    Swerdlow, Steven H.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2013, 37 (03) : 323 - 332
  • [7] B-cell lymphomas with concurrent MYC and BCL2 abnormalities other than translocations behave similarly to MYC/BCL2 double-hit lymphomas
    Li, Shaoying
    Seegmiller, Adam C.
    Lin, Pei
    Wang, Xuan J.
    Miranda, Roberto N.
    Bhagavathi, Sharathkumar
    Medeiros, L. Jeffrey
    MODERN PATHOLOGY, 2015, 28 (02) : 208 - 217
  • [8] MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas
    Huang, Wenting
    Medeiros, L. Jeffrey
    Lin, Pei
    Wang, Wei
    Tang, Guilin
    Khoury, Joseph
    Konoplev, Sergej
    Yin, C. Cameron
    Xu, Jie
    Oki, Yasuhiro
    Li, Shaoying
    MODERN PATHOLOGY, 2018, 31 (09) : 1470 - 1478
  • [9] Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas
    Menguy, Sarah
    Frison, Eric
    Prochazkova-Carlotti, Martina
    Dalle, Stephane
    Dereure, Olivier
    Boulinguez, Serge
    Dalac, Sophie
    Machet, Laurent
    Ram-Wolff, Caroline
    Verneuil, Laurence
    Gros, Audrey
    Vergier, Beatrice
    Beylot-Barry, Marie
    Merlio, Jean-Philippe
    Pham-Ledard, Anne
    MODERN PATHOLOGY, 2018, 31 (08) : 1332 - 1342
  • [10] Double-hit and dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas
    Menguy, Sarah
    Frison, Eric
    Prochazkova-Carlotti, Martina
    Dalle, Stephane
    Dereure, Olivier
    Boulinguez, Serge
    Dalac, Sophie
    Machet, Laurent
    Ram-Wolff, Caroline
    Verneuil, Laurence
    Gros, Audrey
    Vergier, Beatrice
    Beylot-Barry, Marie
    Merlio, Jean-Philippe
    Pham-Ledard, Anne
    EUROPEAN JOURNAL OF CANCER, 2019, 119 : S20 - S20
12345